Ionis Pharmaceuticals Inc. (NASDAQ: IONS) Announce Update Regarding Vupanorsen Study In...

0
Ionis Pharmaceuticals Inc. (NASDAQ: IONS) has announced that Pfizer Inc. (NYSE: PFE) has given an update on the Phase 2b vupanorsen study. Vupanorsen is...

Artelo Biosciences Inc. (NASDAQ: ARTL) Announce Fiscal Year 2021 Results And...

0
Artelo Biosciences Inc. (NASDAQ: ARTL) has announced its operating and financial results for the fiscal year ending August 31, 2021, and offered a business...

Popular News

MAKE IT MODERN

LATEST REVIEWS

IVERIC bio Inc. (NASDAQ:ISEE) Says the Results From its GATHER1 Phase...

0
IVERIC bio Inc (NASDAQ:ISEE) has had consistent success in the development of treatments addressing age-related and retinal diseases. Zimura® (avacincaptad pegol) is one of...

MAKE IT MODERN

PERFORMANCE TRAINING

Napo Pharmaceuticals Inc, A Subsidiary Of Jaguar Health Inc (NASDAQ:JAGX), Negotiates With Insurers To...

0
Napo Pharmaceuticals Inc, a wholly-owned subsidiary of Jaguar Health Inc (NASDAQ:JAGX), is in discussions with insurers for better patient access to its Mytesi, plant...

US FDA Grants Approval For Xywav Oral Solution Of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) To...

0
The US FDA granted approval for Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)’s Xywav oral solution to treat excessive sleep during daytime or narcolepsy. Jazz received the FDA...

Aytu BioScience Inc. (NASDAQ:AYTU) Announces The Improvement Of Nastesto To Preferred Brands On Express...

0
Aytu BioScience Inc. (NASDAQ:AYTU) announced that Express Scripts Inc., which is among leading pharmacy benefit managers in the US, will make testosterone nasal gel,...

Artelo Biosciences Inc (NASDAQ:ARTL) Posts Net Loss Of $951,395 In Q3 2020

0
Artelo Biosciences Inc (NASDAQ:ARTL) widened net loss by 175.80% to $951,395 in Q3 2020. Its operating expenses related to R&D, administrative and general expenses...

iBiO Inc. (NYSEAMERICAN:IBIO) Enters Agreement To Produce ATB Therapeutics’ Antibody-Toxin Fusion Proteins

0
Biologics contract development and manufacturing organization (CDMO), iBiO Inc. (NYSEAMERICAN:IBIO) has announced the signing of its first Statement of Work under a Master Services...

MAKE IT MODERN

POPULAR

[/tdc_zone]